Schering in talks over Mitsui division purchase:
This article was originally published in Clinica
Schering has confirmed it is in negotiations with Mitsui over the possible sale of the Japanese company's pharmaceutical division, which includes some X-ray contrast media. The German company would give no further details, but local Japanese press reports indicate that a contract could be signed as early as this month. The division would be integrated into Schering's Japanese unit, Nihon Schering KK, the press report says. Schering recently announced plans to buy US company Diatide and a major stake in ORIS/CIS Bio International of France.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.